Vancouver, Canada

Andrés Rodríguez Esmeral

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Andrés Rodríguez Esmeral

Introduction

Andrés Rodríguez Esmeral is an accomplished inventor based in Vancouver, Canada. He has made significant contributions to the field of clinical trials through his innovative patent. His work focuses on enhancing the efficiency and effectiveness of clinical trials, which is crucial for medical advancements.

Latest Patents

Andrés holds a patent for "Systems and methods for virtual clinical trials." This technology relates to a system and method for assigning participants to groups in a clinical trial. The system includes a federated server configured with group assignability data specifying a plurality of groups assignable to participants in a clinical trial and group distribution data specifying the distribution of the participants into groups. The groups include at least one placebo group and one or more treatment groups. The system also features an intervention server configured to generate group encryption keys for encrypting the group assignability data. Additionally, the system includes edge devices for each of the participants, which are in communication with the federated server.

Career Highlights

Andrés is currently employed at Sharecare AI, Inc., where he continues to develop innovative solutions in the healthcare sector. His work at Sharecare AI, Inc. reflects his commitment to improving clinical trial methodologies and patient outcomes.

Collaborations

Andrés has collaborated with notable professionals in his field, including Srivatsa Akshay Sharma and Walter Adolf De Brouwer. These collaborations have further enriched his work and contributed to the advancement of clinical trial technologies.

Conclusion

Andrés Rodríguez Esmeral is a pioneering inventor whose work in virtual clinical trials is shaping the future of medical research. His innovative approach and dedication to improving clinical trial processes are commendable and impactful.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…